EP Patent

EP3666778A1 — A crystalline cyclic boronic acid ester derivative, method for the preparation and therapeutic uses thereof

Assigned to Melinta Subsidiary Corp · Expires 2020-06-17 · 6y expired

What this patent protects

Disclosed herein are antimicrobial compounds compositions, pharmaceutical compositions, the use and preparation thereof. Some embodiments relate to 1 cyclic boronic acid ester derivatives and their use as therapeutic agents.

USPTO Abstract

Disclosed herein are antimicrobial compounds compositions, pharmaceutical compositions, the use and preparation thereof. Some embodiments relate to 1 cyclic boronic acid ester derivatives and their use as therapeutic agents.

Drugs covered by this patent

Patent Metadata

Patent number
EP3666778A1
Jurisdiction
EP
Classification
—
Expires
2020-06-17
Drug substance claim
No
Drug product claim
No
Assignee
Melinta Subsidiary Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.